Wendy B. Young

1.4k total citations
13 papers, 297 citations indexed

About

Wendy B. Young is a scholar working on Genetics, Hematology and Oncology. According to data from OpenAlex, Wendy B. Young has authored 13 papers receiving a total of 297 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Genetics, 8 papers in Hematology and 4 papers in Oncology. Recurrent topics in Wendy B. Young's work include Blood Coagulation and Thrombosis Mechanisms (7 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Wendy B. Young is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (7 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Wendy B. Young collaborates with scholars based in United States, Switzerland and Canada. Wendy B. Young's co-authors include Paul A. Sprengeler, Roopa Rai, Lawrence B. Snyder, John J. Masters, Samuel J. Danishefsky, J. T. Link, Lawrence G. Lum, Jonathan M. Gall, Leslie P. Cousens and Pamela A. Davol and has published in prestigious journals such as Blood, Cancer Research and Clinical Cancer Research.

In The Last Decade

Wendy B. Young

13 papers receiving 283 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wendy B. Young United States	8	100	93	90	70	68	13	297
Johannes J.M. Rood Netherlands	11	127 1.3×	83 0.9×	108 1.2×	195 2.8×	40 0.6×	16	360
Daniel Kukral United States	8	35 0.3×	23 0.2×	68 0.8×	105 1.5×	61 0.9×	9	265
Kwee Hyun Suh South Korea	9	78 0.8×	39 0.4×	150 1.7×	141 2.0×	69 1.0×	32	341
Lesley Liu‐Bujalski United States	7	192 1.9×	70 0.8×	62 0.7×	146 2.1×	50 0.7×	10	346
Edwin de Zwart United States	6	252 2.5×	106 1.1×	61 0.7×	104 1.5×	65 1.0×	7	356
Jeff Keats United States	3	133 1.3×	215 2.3×	77 0.9×	131 1.9×	106 1.6×	4	363
Bas van de Kar Netherlands	8	325 3.3×	129 1.4×	75 0.8×	150 2.1×	85 1.3×	10	462
Hardik J. Patel United States	9	68 0.7×	50 0.5×	45 0.5×	82 1.2×	37 0.5×	13	220
Noriko Konishi Japan	12	25 0.3×	63 0.7×	31 0.3×	56 0.8×	73 1.1×	27	317
Vidhyashankar Ramamurthy United States	9	85 0.8×	60 0.6×	27 0.3×	157 2.2×	47 0.7×	9	273

Countries citing papers authored by Wendy B. Young

Since Specialization

Citations

This map shows the geographic impact of Wendy B. Young's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wendy B. Young with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wendy B. Young more than expected).

Fields of papers citing papers by Wendy B. Young

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wendy B. Young. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wendy B. Young. The network helps show where Wendy B. Young may publish in the future.

Co-authorship network of co-authors of Wendy B. Young

This figure shows the co-authorship network connecting the top 25 collaborators of Wendy B. Young. A scholar is included among the top collaborators of Wendy B. Young based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wendy B. Young. Wendy B. Young is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Reiff, Sean D., Daphne Guinn, Amy Lehman, et al.. (2018). Noncovalent inhibition of C481S Bruton tyrosine kinase by GDC-0853: a new treatment strategy for ibrutinib-resistant CLL. Blood. 132(10). 1039–1049. 51 indexed citations

Schutt, Leah, Jacqueline M. Tarrant, Michelle McDowell, et al.. (2016). Bruton’s Tyrosine Kinase Small Molecule Inhibitors Induce a Distinct Pancreatic Toxicity in Rats. Journal of Pharmacology and Experimental Therapeutics. 360(1). 226–238. 12 indexed citations

Choy, Regina, Luciana Burton, Wendy B. Young, et al.. (2015). Abstract 136: Evaluation of reversible BTK inhibitors in cell lines with clinically relevant Ibrutinib resistance mutations. Cancer Research. 75(15_Supplement). 136–136. 1 indexed citations

Cousens, Leslie P., et al.. (2006). Human T Cells Armed with Her2/neu Bispecific Antibodies Divide, Are Cytotoxic, and Secrete Cytokines with Repeated Stimulation. Clinical Cancer Research. 12(2). 569–576. 63 indexed citations

Rai, Roopa, Michael B. Shaghafi, Ellen M. Leahy, et al.. (2006). Efforts toward oral bioavailability in factor VIIa inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(14). 3829–3832. 5 indexed citations

Hu, Huiyong, Aleksandr Kolesnikov, Jennifer R. Riggs, et al.. (2006). Potent 4-amino-5-azaindole factor VIIa inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(17). 4567–4570. 26 indexed citations

Riggs, Jennifer R., Huiyong Hu, Aleksandr Kolesnikov, et al.. (2006). Novel 5-azaindole factor VIIa inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(12). 3197–3200. 19 indexed citations

Young, Wendy B., et al.. (2006). Factor VIIa Inhibitors: Chemical Optimization, Preclinical Pharmacokinetics, Pharmacodynamics, and Efficacy in an Arterial Baboon Thrombosis Model.. ChemInform. 37(29). 1 indexed citations

Dalrymple, Stacie A., et al.. (2005). A Selective Small Molecule Factor VIIa Inhibitor, CRA-027483, Suppresses Acute Inflammation in Mice.. Blood. 106(11). 3089–3089. 1 indexed citations

10.

Davol, Pamela A., Jonathan M. Gall, Wendy B. Young, et al.. (2004). Infusions of T Cells Armed with Anti-CD3 x Anti-Her2/neu Bispecific Antibody Modulate In Vivo Patient Immune Responses in Phase I Clinical Trials for Breast and Hormone Refractory Prostate Cancers.. Blood. 104(11). 1349–1349. 5 indexed citations

11.

Rai, Roopa, et al.. (2001). Perspectives on Factor Xa Inhibition. Current Medicinal Chemistry. 8(2). 101–119. 58 indexed citations

12.

Schipper, Nicolaas, et al.. (2001). In Vitro Intestinal Permeability of Factor Xa Inhibitors: Influence of Chemical Structure on Passive Transport and Susceptibility to Efflux. Pharmaceutical Research. 18(12). 1735–1741. 12 indexed citations

13.

Masters, John J., J. T. Link, Lawrence B. Snyder, Wendy B. Young, & Samuel J. Danishefsky. (1995). Eine Totalsynthese von Taxol. Angewandte Chemie. 107(16). 1886–1888. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact